Eloxatin

A drug used to treat colorectal cancer that is advanced or has come back. It is also being studied in the treatment of other types of cancer. Eloxatin belongs to the family of drugs called platinum compounds. Also called oxaliplatin.

English dictionary of cancer terms . 2015.

Look at other dictionaries:

  • Eloxatin — Elox·a·tin (e lokґsə tin) trademark for a preparation of oxaliplatin …   Medical dictionary

  • Oxaliplatin — Systematic (IUPAC) name [(1R,2 …   Wikipedia

  • Debiopharm — Group™ Type Société Anonyme Industry biopharmaceutical Founded Lausanne, Switzerland (1979) Founder(s) Dr Rolland Yves Mauvernay Headquarters …   Wikipedia

  • FOLFOX — is a chemotherapy regimen for treatment of colorectal cancer, made up of the drugs * FOL– Folinic acid (leucovorin) * F – Fluorouracil (5 FU) * OX – Oxaliplatin (Eloxatin) [ [http://www.cancerhelp.org.uk/help/default.asp?page=15970 Cancer… …   Wikipedia

  • Hospira — Hospira, Inc. Type Public (NYSE: HSP) Founded Lake Forest, Illinois (May 3, 2004) …   Wikipedia

  • Debiopharm — 46° 30′ 54″ N 6° 38′ 28″ E / 46.514955, 6.641142 …   Wikipédia en Français

  • Colorectal cancer — Classification and external resources Diagram of the lower gastrointestinal tract ICD 10 C …   Wikipedia

  • FOLFOX — Das FOLFOX4 Regime ist ein Therapieschema Standard (EbM Level II) in der adjuvanten oder palliativen Chemotherapie zur Behandlung des kolorektalen Karzinoms im UICC Stadium III. Die Therapie wird 14 täglich in zwölf Zyklen nach folgendem Schema… …   Deutsch Wikipedia

  • FOLFOX4 — Das FOLFOX4 Regime ist ein Therapieschema Standard (EbM Level II) in der adjuvanten oder palliativen Chemotherapie zur Behandlung des kolorektalen Karzinoms im UICC Stadium III. Die Therapie wird 14 täglich in 12 Zyklen nach folgendem Schema… …   Deutsch Wikipedia

  • Oxaliplatin — Strukturformel Allgemeines Freiname Oxaliplatin A …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.